Published in J Appl Physiol (1985) on December 19, 2013
The role of elastic restoring forces in right-ventricular filling. Cardiovasc Res (2015) 1.39
RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart (2014) 1.26
Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series). Pulm Circ (2014) 0.90
Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res (2014) 0.83
Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. Int J Cardiol (2016) 0.82
Venous thromboembolism and subsequent permanent work-related disability. J Thromb Haemost (2016) 0.82
Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment. F1000Prime Rep (2014) 0.81
RV diastolic dysfunction: time to re-evaluate its importance in heart failure. Heart Fail Rev (2015) 0.76
Putting "at-rest" evaluations of the right ventricle to rest: insights gained from evaluation of the right ventricle during exercise in CTEPH patients with and without pulmonary endarterectomy. J Am Heart Assoc (2015) 0.75
Ventriculo-arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease. Physiol Rep (2017) 0.75
Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension. Pulm Circ (2017) 0.75
Prostacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure-overloaded human right heart. Pulm Circ (2017) 0.75
Right Ventricular-Pulmonary Vascular Interactions. Physiology (Bethesda) (2017) 0.75
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res (1973) 3.87
Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation (1984) 2.57
Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation (2009) 2.17
Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation (2004) 2.12
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest (2007) 1.74
Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol (2001) 1.65
Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol (2003) 1.58
Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation (1986) 1.47
Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation (2013) 1.35
Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart (2011) 1.33
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail (2011) 1.30
Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail (2012) 1.23
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail (2013) 1.21
Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation. Ann Thorac Surg (2010) 1.18
Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. Am J Physiol Heart Circ Physiol (2010) 1.18
Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res (1981) 1.16
Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol (2003) 1.13
Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation (2000) 1.13
Indexes of diastolic RV function: load dependence and changes after chronic RV pressure overload in lambs. Am J Physiol Heart Circ Physiol (2002) 1.10
Validation of a new intraoperative technique to evaluate load-independent indices of right ventricular performance in patients undergoing cardiac operations. J Thorac Cardiovasc Surg (1998) 1.04
Increased airway pressure and simulated branch pulmonary artery stenosis increase pulmonary regurgitation after repair of tetralogy of Fallot. Real-time analysis with a conductance catheter technique. Circulation (1997) 0.93
Application of a time varying elastance model to right ventricular performance in man. Cardiovasc Res (1988) 0.89
Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure. J Appl Physiol (1985) (2010) 0.88
Right ventricular diastolic pressure-volume relations and regional dimensions during acute alterations in loading conditions. Circulation (1988) 0.86
Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension. Eur Respir J (2008) 0.83
Cardiac mechanics and energetics--from Emax to PVA. Front Med Biol Eng (1990) 0.81
Right ventricular volume measurement by conductance catheter. Am J Physiol Heart Circ Physiol (2003) 0.81
Resting right ventricular function in patients with coronary artery disease: pressure volume analysis using conductance catheters. Int J Cardiol (1997) 0.80
Right ventricular volume measurement: can conductance do it better? Physiol Meas (2000) 0.79
Right ventricular dysfunction during coronary artery occlusion: pressure-volume analysis using conductance catheters during coronary angioplasty. Heart (1997) 0.79
Continuous monitoring of right ventricular volume changes using a conductance catheter in the rabbit. J Appl Physiol (1985) (1992) 0.79
Left and right ventriculo-arterial coupling in a patient with congenitally corrected transposition. Cardiol Young (2005) 0.78
A new approach to determine parallel conductance for left ventricular volume measurements. Cardiovasc Res (2000) 0.78
Stunning and cumulative left ventricular dysfunction occurs late after coronary balloon occlusion in humans insights from simultaneous coronary and left ventricular hemodynamic assessment. JACC Cardiovasc Interv (2010) 0.77
Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol (2004) 5.79
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation (2009) 4.61
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation (2013) 3.90
Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol (2009) 3.75
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med (2008) 3.67
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51
Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res (2005) 3.16
A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J (2011) 3.14
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation (2002) 3.08
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation (2010) 3.02
A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med (2011) 2.89
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest (2008) 2.71
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation (2013) 2.64
Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol (2010) 2.44
Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging (2011) 2.43
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat (2006) 2.30
Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation (2005) 2.21
Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol (2013) 2.07
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med (2012) 2.00
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res (2006) 1.85
Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet (2002) 1.85
Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res (2013) 1.80
MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res (2013) 1.80
Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med (2009) 1.78
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 1.72
Flexibility and diversity in consultant careers. Clin Med (2002) 1.71
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol (2008) 1.69
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med (2010) 1.69
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat (2006) 1.69
Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem (2009) 1.68
Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg (2011) 1.66
A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res (2012) 1.61
Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2015) 1.60
Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. Am J Respir Crit Care Med (2011) 1.59
Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension. Circulation (2012) 1.59
Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 1.58
Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol (2011) 1.57
Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.56
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2008) 1.52
Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation. Catheter Cardiovasc Interv (2014) 1.52
Validation of myocardial acceleration during isovolumic contraction as a novel noninvasive index of right ventricular contractility: comparison with ventricular pressure-volume relations in an animal model. Circulation (2002) 1.51
Functional MR imaging: comparison of BOLD signal intensity changes in fetal organs with fetal and maternal oxyhemoglobin saturation during hypoxia in sheep. Radiology (2006) 1.51
Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum Mol Genet (2003) 1.44
Brain death leads to abnormal contractile properties of the human donor right ventricle. J Thorac Cardiovasc Surg (2006) 1.44
DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circ Cardiovasc Imaging (2010) 1.40
Inferior ST-segment elevation following transseptal puncture for balloon mitral valvuloplasty is atropine-responsive. J Invasive Cardiol (2004) 1.40
Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation (2005) 1.40
ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2002) 1.39
Clinical application of magnetic resonance spectroscopy of the liver in patients receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr (2009) 1.37
Sources, fate, and toxic hazards of oxygenated polycyclic aromatic hydrocarbons (PAHs) at PAH-contaminated sites. Ambio (2007) 1.35
Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg (2010) 1.32
Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries. Pulm Circ (2011) 1.31
BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet (2013) 1.29
New and emerging technologies for genetic toxicity testing. Environ Mol Mutagen (2010) 1.28
Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol (2009) 1.22
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat (2011) 1.18
Air pollution induces heritable DNA mutations. Proc Natl Acad Sci U S A (2002) 1.18
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology (2012) 1.18
MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res (2011) 1.15
Noninvasive assessment of left ventricular force-frequency relationships using tissue Doppler-derived isovolumic acceleration: validation in an animal model. Circulation (2003) 1.15
Time-of-day influences on static and dynamic postural control. J Athl Train (2007) 1.14
The mutagenic hazards of settled house dust: a review. Mutat Res (2004) 1.14
Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology. Circ Cardiovasc Imaging (2013) 1.13
Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2006) 1.13
Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circ Cardiovasc Interv (2013) 1.13
Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest (2010) 1.12
Systemic ventricular function in patients with transposition of the great arteries after atrial repair: a tissue Doppler and conductance catheter study. J Am Coll Cardiol (2004) 1.12
Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Hum Mol Genet (2008) 1.11
Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation (2012) 1.11
Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest (2008) 1.11
Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys (2008) 1.10
BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways. Am J Physiol Lung Cell Mol Physiol (2004) 1.09
The renin-angiotensin system in pulmonary hypertension. Am J Respir Crit Care Med (2013) 1.08
No closure for patent foramen ovale in obstructive sleep apnea? Chest (2013) 1.08
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2007) 1.08
Pulmonary endarterectomy: outcomes in patients aged >70. Eur J Cardiothorac Surg (2012) 1.08
Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ Res (2013) 1.08
Partial contributions of developmental hypoxia and undernutrition to prenatal alterations in somatic growth and cardiovascular structure and function. Am J Obstet Gynecol (2010) 1.07
Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ (2012) 1.06
Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.06
Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells. Mol Pharmacol (2007) 1.06
Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.06
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation (2002) 1.06
BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol (2012) 1.06
The mutagenic hazards of aquatic sediments: a review. Mutat Res (2004) 1.06
Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate. Chest (2006) 1.05
Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J Biol Chem (2010) 1.05
Transradial coronary angiography in patients with contraindications to the femoral approach: an analysis of 500 cases. Catheter Cardiovasc Interv (2004) 1.05
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension. Thorax (2011) 1.04
Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Circulation (2007) 1.04